Henry Schein, Inc. (HSIC)
NASDAQ: HSIC · Real-Time Price · USD
74.57
-0.68 (-0.90%)
Nov 28, 2025, 1:00 PM EST - Market closed
Henry Schein Revenue
Henry Schein had revenue of $3.34B in the quarter ending September 27, 2025, with 5.20% growth. This brings the company's revenue in the last twelve months to $12.94B, up 3.51% year-over-year. In the year 2024, Henry Schein had annual revenue of $12.67B with 2.71% growth.
Revenue (ttm)
$12.94B
Revenue Growth
+3.51%
P/S Ratio
0.71
Revenue / Employee
$517,520
Employees
25,000
Market Cap
8.78B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 28, 2024 | 12.67B | 334.00M | 2.71% |
| Dec 30, 2023 | 12.34B | -308.00M | -2.44% |
| Dec 31, 2022 | 12.65B | 246.00M | 1.98% |
| Dec 25, 2021 | 12.40B | 2.28B | 22.55% |
| Dec 26, 2020 | 10.12B | 133.20M | 1.33% |
| Dec 28, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 29, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 26, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
HSIC News
- 3 days ago - Artisan Select Equity Fund Q3 2025 Portfolio Review - Seeking Alpha
- 5 days ago - Henry Schein One Unveils Industry-first Natively Embedded Voice Workflow at 2025 Greater New York Dental Meeting - Business Wire
- 10 days ago - American Century Mid Cap Value Fund Q3 2025 Contributors/Detractors And Notable Trades - Seeking Alpha
- 12 days ago - Henry Schein, Inc. (HSIC) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 17 days ago - Worried About an AI Bubble? Here Are BofA's Top Stock Picks to Diversify Your Portfolio - Investopedia
- 17 days ago - Henry Schein to Participate in Upcoming Investor Conference in December - Business Wire
- 18 days ago - Henry Schein, Inc. (HSIC) Presents at Stifel 2025 Healthcare Conference Transcript - Seeking Alpha
- 20 days ago - Nuance Investments Dumps $38 Million in Henry Schein (NASDAQ: HSIC) Shares: Should Investors Sell Too? - The Motley Fool